Noncardiovascular Cause of Death More Common in CHD Patients

Share this content:
Noncardiovascular Cause of Death More Common in CHD Patients
Noncardiovascular Cause of Death More Common in CHD Patients

MONDAY, Dec. 19, 2016 (HealthDay News) -- For patients with coronary heart disease (CHD), mortality is more often due to noncardiovascular causes, according to a study published in the Jan. 1 issue of The American Journal of Cardiology.

Elizabeth Y. Wang, from the University of California in San Francisco, and colleagues determined the proportion of patients with CHD who died from cardiovascular versus noncardiovascular causes and the causes and predictors of death. A total of 1,024 participants from the Heart and Soul Study with stable CHD were enrolled from 2000 to 2002 and followed for 10 years.

The researchers found that 401 participants died during 7,680 person-years of follow-up. Of these deaths, 42.4 and 54.4 percent, respectively, were cardiovascular and noncardiovascular. Seventy-two percent of cardiovascular deaths were accounted for by myocardial infarction, stroke, and sudden death. Sixty-seven percent of noncardiovascular deaths were accounted for by cancer, pneumonia, and sepsis. Older age, inducible ischemia on stress echocardiography, higher heart rate at rest, smoking, lower hemoglobin, and higher N-terminal pro-brain natriuretic peptide were independent predictors of cardiac mortality (all P < 0.05). Older age, inducible ischemia, higher heart rate, lower exercise capacity, and nonuse of statins were independent predictors of noncardiac mortality (all P < 0.05).

"In conclusion, mortality in this cohort was more frequently due to noncardiovascular causes, and predictors of noncardiovascular mortality included factors traditionally associated with cardiovascular mortality," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Belimumab Aids Anti-dsDNA, Hypocomplementemic Lupus

Belimumab Aids Anti-dsDNA&#43;, Hypocomplementemic Lupus

More SLE Responder Index responders at week 52 in the belimumab group versus the placebo group

Too Few Adults Taking Epilepsy Meds Have Seizure Control

Too Few Adults Taking Epilepsy Meds Have Seizure ...

Ninety percent of those with active epilepsy take meds; 44 percent of those report seizure control

Pediatric Exposures to Liquid Nicotine Down From 2015 to 2016

Pediatric Exposures to Liquid Nicotine Down From 2015 ...

Still poses serious risk to children; decrease likely in part to law requiring child-resistant packaging

is free, fast, and customized just for you!

Already a member?

Sign In Now »